Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy
Open Access
Abstract
Recently, cancer immunotherapy has received attention as a viable solution for the treatment of refractory tumors. However, it still has clinical limitations in its treatment efficacy due to inter-patient tumor heterogeneity and immunosuppressive tumor microenvironment (TME). In this study, we demonstrated the triggering of anti-cancer immune responses by a combination of irreversible electroporation (IRE) and a stimulator of interferon genes (STING) agonist. Optimal electrical conditions inducing damage-associated molecular patterns (DAMPs) by immunogenic cell death (ICD) were determined through in vitro 2D and 3D cell experiments. In the in vivo syngeneic lung cancer model, the combination of IRE and STING agonists demonstrated significant tumor growth inhibition. We believe that the combination strategy of IRE and STING agonists has potential for effective cancer immunotherapy.Keywords
Funding Information
- National Research Foundation of Korea (2018R1C1B6001120, 2020M2D9A3094208, 2020R1A2C2004530, 2020R1A2B5B03002344)
This publication has 54 references indexed in Scilit:
- Impact of the Use of Nanoparticles on Electric Field Distribution during Irreversible Electroporation Treatments: Can the Lesion be Enhanced Beyond IRE Margin?2015
- Irreversible Electroporation for Nonthermal Tumor Ablation in the Clinical Setting: A Systematic Review of Safety and EfficacyJournal of Vascular and Interventional Radiology, 2014
- Innate and adaptive immune cells in the tumor microenvironmentNature Immunology, 2013
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structuresJournal of Surgical Oncology, 2012
- Low voltage irreversible electroporation induced apoptosis in HeLa cellsJournal of Cancer Research and Therapeutics, 2012
- Investigation of the Safety of Irreversible Electroporation in HumansJournal of Vascular and Interventional Radiology, 2011
- MR Imaging to Assess Immediate Response to Irreversible Electroporation for Targeted Ablation of Liver Tissues: Preclinical Feasibility Studies in a Rodent ModelRadiology, 2010
- Tumor Ablation with Irreversible ElectroporationPLOS ONE, 2007
- Tissue Ablation with Irreversible ElectroporationAnnals of Biomedical Engineering, 2005